GlaxoSmithKline and SK bioscience start late-stage trial for COVID-19 vaccine candidate
Over the current book year the total revenue will be 33.28 billion GBp (consensus estimates). This is slightly lower than 2021's revenue of 34.1 billion GBp.
Historical revenues and results GlaxoSmithKline plus estimates 2021
The analysts expect for 2021 a net profit of 5.07 billion GBp. For this year the consensus of the result per share is a profit of 101 GBp. The PE-ratio therefore is 14.62.
Huge dividend GlaxoSmithKline
Per share the analysts anticipate on a dividend of 79 GBp per share. The dividend yield is then 5.35 percent. The average dividend yield of the pharmaceutical companies equals a limited 1.37 percent.Recent target prices around 1637 GBp
UBS , JP Morgan and Goldman Sachs recently provided recommendations for the stock.GlaxoSmithKline 's market value equals around 7311.96 billion . 6
At 17.45 the stock trades 0.18 percent higher at 1476.2 GBp.Historical stock prices GlaxoSmithKline2007-2021
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
news@valuespectrum.com
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.
| About us | Network | Partners |
| Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos |
Analist.nlLinksISIN
|
MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-x
|
